Cargando…
Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives
One of the most common malignancies affecting adults with the neurofibromatosis type 1 (NF1) cancer predisposition syndrome is the malignant peripheral nerve sheath tumor (MPNST), a highly aggressive sarcoma that typically develops from benign plexiform neurofibromas. Approximately 8–13% of individu...
Autores principales: | Prudner, Bethany C, Ball, Tyler, Rathore, Richa, Hirbe, Angela C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317062/ https://www.ncbi.nlm.nih.gov/pubmed/32642731 http://dx.doi.org/10.1093/noajnl/vdz047 |
Ejemplares similares
-
Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1
por: Godec, Abigail, et al.
Publicado: (2019) -
Genetics of human malignant peripheral nerve sheath tumors
por: Pemov, Alexander, et al.
Publicado: (2019) -
Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors
por: Hirbe, Angela C., et al.
Publicado: (2017) -
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)
por: Lopez, Gonzalo, et al.
Publicado: (2015) -
TYK2 promotes malignant peripheral nerve sheath tumor progression through inhibition of cell death
por: Qin, Wenjing, et al.
Publicado: (2019)